Skip to Content

Additional Content In This Section

VariZIG

Objective

Status

Available

Condition

Exposure to chicken pox and before development of the disease

Purpose

Approved for the treatment of people at-risk of developing serious complications after being exposed to someone with chicken pox, but before the development of chicken pox.

Phase

Compassionate  use

Key Inclusion Criteria

Patients whose doctors determine they are at risk of developing severe complications to chicken pox.

Key Exclusion Criteria

Known immunity to Varicella Zoster Virus, evidence of Varicella infection.

ClinicalTrials.gov Identifier

NCT00338442

IRB Protocol Number
VZ 009
Principal Investigator(s)
James Hargreaves, DO

Clinical Trial Categories

  • Infectious Disease
Sponsor(s)
Cangene Corporation
Contact
Renee Hendrickson, RN CCRC at 701-780-1694
or rhendrickson@altru.org